Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004934

Locations


United States, Minnesota
	St. Mary's/Duluth Clinic Cancer Center
	Duluth, Minnesota, United States, 55805

Belgium
	U.Z. Gasthuisberg
	Leuven, Belgium, B-3000

Canada, Alberta
	Tom Baker Cancer Center - Calgary
	Calgary, Alberta, Canada, T2N 4N2

Canada, Manitoba
	CancerCare Manitoba
	Winnipeg, Manitoba, Canada, R3E 0V9

Canada, Ontario
	Cancer Care Ontario-Hamilton Regional Cancer Centre
	Hamilton, Ontario, Canada, L8V 5C2

Canada, Quebec
	Centre Hospitalier Universitaire de Quebec
	Quebec City, Quebec, Canada, G1R 2J6
	CHUS-Hopital Fleurimont
	Fleurimont, Quebec, Canada, J1H 5N4

Denmark
	Aalborg Hospital
	Aalborg, Denmark, 9100
	Odense University Hospital
	Odense, Denmark, DK-5000

Israel
	Shaare Zedek Medical Center
	Jerusalem, Israel, 91031

Italy
	Istituto Nazionale per lo Studio e la Cura dei Tumori
	Milano (Milan), Italy, 20133
	Ospedale di Circolo e Fondazione Macchi
	Varese, Italy, 21100
	Spedali Civili
	Brescia, Italy, 25123

Netherlands
	Medisch Spectrum Twente
	Enschede, Netherlands, 7500 KA

Norway
	Norwegian Radium Hospital
	Oslo, Norway, N-0310

Portugal
	Hospitais da Universidade de Coimbra (HUC)
	Coimbra, Portugal, 3049
	Instituto Portugues de Oncologia de Francisco Gentil - Centro de Lisboa
	Lisbon, Portugal, 1099-023 Codex

Spain
	Institut d'Oncologia Corachan
	Barcelona, Spain, 08.017

Sponsors and Collaborators

Nordic Society for Gynaecologic Oncology

European Organization for Research and Treatment of Cancer

National Cancer Institute of Canada

Investigators


Study Chair:	Gunnar B. Kristensen, MD, PhD	Norwegian Radium Hospital

Study Chair:	Ignace B. Vergote, MD, PhD	U.Z. Gasthuisberg

Study Chair:	Gavin C.E. Stuart, MD	Tom Baker Cancer Centre - Calgary